Applicant
Adams NZ Bidco Limited, 2719970 Ontario Limited
Case number(s)
201900631
Decision date
Type
Decision
Decision

Consent granted

Section 12(b) Overseas Investment Act 2005

Section 13(1)(a) Overseas Investment Act 2005

Decision MakerOverseas Investment Office
Decision Date13 March 2020
Pathway(s)

Residential land (non-residential use)

Significant business assets

Investment

An overseas investment in sensitive land, being the acquisition of rights or interests in 100% of the shares of Abano Healthcare Group Limited which owns or controls a leasehold interest in approximately 0.5 hectares of land used for dental premises.

An overseas investment in significant business assets, being the Applicant's acquisition of rights or interests in 100% of the shares of Abano Healthcare Group Limited, the consideration of which exceeds $100m.

Consideration$149,808,756
Applicant

Adams NZ Bidco Limited a New Zealand incorporated company (company number 7807717) that is owned by various pension funds, institutional and other investors located outside of New Zealand

2719970 Ontario Limited

Canada (100%)

Vendor

Existing shareholders of Abano Healthcare Group Limited

New Zealand Public (93.9%)

Various overseas persons (3.1%)

Australian Public (3.0%)

Background

The joint applicants represent two investment groups (the Australian BGH Group and the Canadian OTPP Group).

The overseas investment comprises a targeted takeover of a New Zealand company.

The joint applicants have applied for consent for Adams NZ Bidco to acquire up to 100% of the fully paid ordinary shares in New Zealand incorporated Abano Healthcare Group Limited (Target), along with a related post-acquisition parental entity share restructure.

The Target is listed on the NZX and is the owner of one of the largest dental groups in Australia and New Zealand. It operates through two brands (“Lumino The Dentists” in New Zealand and “Maven Dental Group” in Australia) and engages over 2,300 people across more than 239 dental practices.

The proposed acquisition was announced through the NZX in November 2019.

The proposed investment also requires approval from the High Court, the Australian Foreign Investment Review Board, and the Target’s shareholders.

More information

Glenn Shewan

Bell Gully

PO Box 4199

AUCKLAND 1140

See the attached assessment report linked below, which was published in response to an Official Information Act request:

Consents granted under the Overseas Investment Act 2005 relating to the New Zealand Health Care sector

Related files